Cita APA (7a ed.)

Emens, L. A., Molinero, L., Loi, S., Rugo, H. S., Schneeweiss, A., Diéras, V., . . . Schmid, P. (2021). Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study. Oxford University Press.

Cita Chicago Style (17a ed.)

Emens, Leisha A., et al. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study. Oxford University Press, 2021.

Cita MLA (8a ed.)

Emens, Leisha A., et al. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study. Oxford University Press, 2021.